{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:26:03Z","timestamp":1780496763626,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,3]],"date-time":"2013-03-03T00:00:00Z","timestamp":1362268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-114","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T15:04:22Z","timestamp":1362409462000},"source":"Crossref","is-referenced-by-count":18,"title":["Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand"],"prefix":"10.1186","volume":"13","author":[{"given":"Leonardo M","family":"Simonella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collette","family":"Bromhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,3]]},"reference":[{"issue":"14","key":"2342_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97 (14): 1072-1079. 10.1093\/jnci\/dji187.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2342_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","volume":"337","author":"M Schiffman","year":"2005","unstructured":"Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D: The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005, 337 (1): 76-84. 10.1016\/j.virol.2005.04.002.","journal-title":"Virology"},{"issue":"10","key":"2342_CR3","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S, Clifford GM: Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer. 2012, 131 (10): 2349-59. 10.1002\/ijc.27485.","journal-title":"Int J Cancer"},{"issue":"1","key":"2342_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","volume":"89","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Aguado T, Franceschi S: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003, 89 (1): 101-105. 10.1038\/sj.bjc.6601024.","journal-title":"Br J Cancer"},{"issue":"Supplement 3","key":"2342_CR5","first-page":"C22","volume":"25","author":"X Castellsagu\u00e9","year":"2007","unstructured":"Castellsagu\u00e9 X, de Sanjos\u00e9 S, Aguado T, Louie KS, Bruni L, Mu\u00f1oz J, Diaz M, Irwin K, Gacic M, Beauvais O: HPV and Cervical Cancer in the World: 2007 Report. Vaccine. 2007, 25 (Supplement 3): C22-","journal-title":"Vaccine"},{"key":"2342_CR6","volume-title":"Topics @ a glance \u2013 Aboriginal and Torres Strait Islander Peoples Population","author":"Australian Bureau of Statistics","year":"2007","unstructured":"Australian Bureau of Statistics: Topics @ a glance \u2013 Aboriginal and Torres Strait Islander Peoples Population. 2007, Canberra: Australian Bureau of Statistics, http:\/\/www.abs.gov.au\/websitedbs\/c311215.nsf\/web\/Aboriginal+and+Torres+Strait+Islander+Peoples+-+Population ISBN Topics @ a glance \u2013 Aboriginal and Torres Strait Islander Peoples Population"},{"key":"2342_CR7","volume-title":"2006 Census","author":"Statistics New Zealand","year":"2007","unstructured":"Statistics New Zealand: 2006 Census. 2007, Wellington: Statistics New Zealand, http:\/\/www.stats.govt.nz\/Census\/2006CensusHomePage.aspx ,"},{"issue":"2","key":"2342_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.vaccine.2007.10.057","volume":"26","author":"JM Brotherton","year":"2008","unstructured":"Brotherton JM: How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine. 2008, 26 (2): 250-256. 10.1016\/j.vaccine.2007.10.057.","journal-title":"Vaccine"},{"issue":"7","key":"2342_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jmv.21515","volume":"81","author":"MP Stevens","year":"2009","unstructured":"Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN: HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol. 2009, 81 (7): 1283-1291. 10.1002\/jmv.21515.","journal-title":"J Med Virol"},{"issue":"1","key":"2342_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jmv.20330","volume":"76","author":"B Brestovac","year":"2005","unstructured":"Brestovac B, Harnett GB, Smith DW, Shellam GR, Frost FA: Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol. 2005, 76 (1): 106-110. 10.1002\/jmv.20330.","journal-title":"J Med Virol"},{"issue":"1","key":"2342_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1741-7015-9-104","volume":"9","author":"SM Garland","year":"2011","unstructured":"Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN, group tWs: Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med. 2011, 9 (1): 104-10.1186\/1741-7015-9-104.","journal-title":"BMC Med"},{"key":"2342_CR12","volume-title":"National Implementation Strategic overview","author":"HPV Project Team","year":"2008","unstructured":"HPV Project Team: The HPV (Human papillomavirus) Immunisation Programme. National Implementation Strategic overview. 2008, New Zealand: Ministry of Health: Public Health Department, Ministry of Health"},{"key":"2342_CR13","doi-asserted-by":"publisher","first-page":"c3493","DOI":"10.1136\/bmj.c5128","volume":"341","author":"J Dillner","year":"2010","unstructured":"Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Future I-II Study Group: Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010, 341: c3493-","journal-title":"BMJ"},{"issue":"19","key":"2342_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"Future II group","year":"2007","unstructured":"Future II group: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007, 356 (19): 1915-1927.","journal-title":"N Engl J Med"},{"key":"2342_CR15","volume-title":"National Cervical Screening Programme Monitoring Reports","author":"M Smith","year":"2010","unstructured":"Smith M, Walker R, Clements M, Canfell K: National Cervical Screening Programme Monitoring Report Number 32, 1 July - 31 December 2009. National Cervical Screening Programme Monitoring Reports. Edited by: Register NCSP. 2010, New Zealand: Ministry of Health National Screening Unit"},{"key":"2342_CR16","volume-title":"Bethesda 2001 New Zealand Modified: Codes, descriptors and assessment of sample adequacy for cytology laboratories","author":"New Zealand National Cervical Screening Programme","year":"2005","unstructured":"New Zealand National Cervical Screening Programme: Bethesda 2001 New Zealand Modified: Codes, descriptors and assessment of sample adequacy for cytology laboratories. 2005, New Zealand: New Zealand National Cervical Screening Programme"},{"issue":"2","key":"2342_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","volume":"103","author":"R Howell-Jones","year":"2010","unstructured":"Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, Anton J, Nichols T, Soldan K, Kitchener H: Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer. 2010, 103 (2): 209-216. 10.1038\/sj.bjc.6605747.","journal-title":"Br J Cancer"},{"issue":"7","key":"2342_CR18","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1128\/JCM.02608-05","volume":"44","author":"MP Stevens","year":"2006","unstructured":"Stevens MP, Rudland E, Garland SM, Tabrizi SN: Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol. 2006, 44 (7): 2428-2433. 10.1128\/JCM.02608-05.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2342_CR19","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1525-1438.2006.00453.x","volume":"16","author":"MP Stevens","year":"2006","unstructured":"Stevens MP, Tabrizi SN, Quinn MA, Garland SM: Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer. 2006, 16 (3): 1017-1024. 10.1111\/j.1525-1438.2006.00453.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2342_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutl\u00e9e F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000, 38 (1): 357-361.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2342_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L: A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol. 2009, 10 (4): 321-322. 10.1016\/S1470-2045(09)70096-8.","journal-title":"Lancet Oncol"},{"key":"2342_CR22","volume-title":"National Cervical Screening Programme Monitoring Report Number 32 1 July \u2013 31 December 2009","author":"M Smith","year":"2011","unstructured":"Smith M, Walker R, Clemens M, Canfell K, Lewis L, Neal H, Maxwell A: National Cervical Screening Programme Monitoring Report Number 32 1 July \u2013 31 December 2009. 2011, New Zealand: New Zealand National Cervical Screening Programme"},{"issue":"2","key":"2342_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jviromet.2007.09.018","volume":"147","author":"MP Stevens","year":"2008","unstructured":"Stevens MP, Garland SM, Tabrizi SN: Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods. 2008, 147 (2): 290-296. 10.1016\/j.jviromet.2007.09.018.","journal-title":"J Virol Methods"},{"issue":"3","key":"2342_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121 (3): 621-632. 10.1002\/ijc.22527.","journal-title":"Int J Cancer"},{"issue":"3","key":"2342_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/1055-9965.EPI-08-0951","volume":"18","author":"C Porras","year":"2009","unstructured":"Porras C, Rodr\u00edguez AC, Hildesheim A, Herrero R, Gonz\u00e1lez P, Wacholder S, Burk RD, Schiffman M: Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev. 2009, 18 (3): 863-865. 10.1158\/1055-9965.EPI-08-0951.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2342_CR26","volume-title":"27th Internation Papillomavirus conference and clinical workshop","author":"J Miyamoto","year":"2011","unstructured":"Miyamoto J, Berkowitz Z, Unger E, Lyu C, Copeland G, Lynch C, Sibug-Saber M, Saraiya M: Vaccine-type HPV distribution in CIN3\/AIS: 3 U.S. cancer registries, 1994\u20132005. 27th Internation Papillomavirus conference and clinical workshop. 2011, Berlin, Germany, 40: Volume Abstract Book 1"},{"issue":"2","key":"2342_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygyno.2011.10.020","volume":"124","author":"L Baandrup","year":"2012","unstructured":"Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kj\u00e6r SK: HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecol Oncol. 2012, 124 (2): 281-285. 10.1016\/j.ygyno.2011.10.020.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2342_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jmv.10220","volume":"68","author":"PE Castle","year":"2002","unstructured":"Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME: Comparisons of HPV DNA detection by MY09\/11 PCR methods. J Med Virol. 2002, 68 (3): 417-423. 10.1002\/jmv.10220.","journal-title":"J Med Virol"},{"key":"2342_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK: Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003, 31: 14-19.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"2342_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1071\/SH09137","volume":"7","author":"JML Brotherton","year":"2010","unstructured":"Brotherton JML, Kaldor JM, Garland SM: Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sexual Health. 2010, 7 (3): 310-319. 10.1071\/SH09137.","journal-title":"Sexual Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-114\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:46:57Z","timestamp":1644454017000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-114","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,3]]},"article-number":"114"}}